IMVT- Immunovant, Inc.

Name: Immunovant, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Immunovant, Inc. (IMVT) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. IMVT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Venker Eric	1.30M	$50.51M	-
CFO	Girao Tiago	247.6K	$9.62M	-10,000
COO	Gloria Melanie	224.4K	$8.72M	-17,714
Other	Stout Jay S	218.4K	$8.49M	-40,000
Other	Geffner Michael	218.0K	$8.47M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 26, 2026	Gloria Melanie	Chief Operating Officer	Sell	17,714	$38.31	$678,604.34	-3.8%	-	-
Jun 26, 2026	Pande Atul74	Director	Sale+OE	1,500	$38.01	$57,015.00	-1.3%	-	-
Jun 26, 2026	Girao Tiago	Chief Financial Officer	Sale+OE	10,000	$38.46	$384,600.00	-3.9%	-	-
Jun 26, 2026	Van Tuyl Christopher	Chief Legal Officer	Sale+OE	17,824	$38.31	$682,886.90	-4.7%	-	-
Jun 26, 2026	Stout Jay S63	Chief Technology Officer	Sell	40,000	$38.31	$1,532,309.48	-8.5%	-	-
May 20, 2026	Pande Atul74	Director	Sale+OE	6,000	$32.00	$192,000.00	-4.9%	-	-
May 1, 2026	Susman Robert Graham	Director	Sell	2,502	$27.17	$67,979.34	-6.4%	-	-
Jan 7, 2026	Stout Jay S63	Chief Technology Officer	Sell	1,203	$26.53	$31,914.08	-0.3%	-7.9%	-
Dec 18, 2025	Van Tuyl Christopher	Chief Legal Officer	Sell	10,813	$26.91	$290,942.54	-3.5%	-9.9%	-
Dec 1, 2025	Hughes Douglas J.	Director	Sell	15,000	$23.24	$348,665.38	-5.8%	+22.0%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC